ArticlePloS one2023
Weed community changes in saffron+chickpea intercropping under different irrigation management.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 6 citations in OpenAlex.
- Impact of following saffron cultivation versus fallow management on yield components of five crop species in two semi-arid regions of Iran.BMC plant biology · 2026Article
- Linking maize root size to phosphorus acquisition and productivity in diversified cropping systems.Frontiers in plant science · 2026Article
- Long-Term Year-Interval Effect of Continuous Maize/Soybean Intercropping on Maize Yield and Phosphorus Use Efficiency.Plants (Basel, Switzerland) · 2025Article
- Effects of saffron-grape intercropping on saffron flower number and rhizosphere microbial community.BMC microbiology · 2024Article
- Enhancing production efficiency through optimizing plant density in maize-soybean strip intercropping.Frontiers in plant science · 2024Article
- Weed community changes in saffron+chickpea intercropping under different irrigation management.PloS one · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Saffron (Crocus sativus L.) is among the world's most expensive crops; nevertheless, it struggles to compete with weeds. Non-chemical farming practices, such as intercropping and reduced irrigation, can help to decrease weed problems. Therefore, this study aimed to evaluate the changes in the weed density, biomass and weed diversity under saffron-chickpea intercropping system with two irrigation regimes. The study's treatments included two irrigation regimes, namely one-time irrigation and conventional irrigation (carried out four times from October through May), and six planting ratios of saffron and chickpea, namely saffron sole-crop (C1), chickpea sole-crop (C2) in eight rows, 1:1 (C3), 2:2 (C4), 2:1 (C5), and 3:1 (C6)] as main and sub-plots, respectively. The result showed that the conventional irrigation regimes increased weed diversity, however, it didn't affect the Pielou index. Intercropping ratios decreased weed diversity compared to saffron and chickpea mono-cropping systems. The interaction effect of treatments was significant for weed density and weed biomass. In most intercropping ratios, weed density and weed biomass decreased under one-time irrigation regimes. The lowest values for weed density and biomass were observed with an average of 15.5 plants/m2 and 37.51 g/m2, respectively, under the one-time irrigation regime with C4 intercropping systems. This intercropping system did not show a significant difference with C3. Overall, the results indicate that a one-time irrigation regime and intercropping with chickpea, specifically with a 1:1 saffron-chickpea ratio (C3) and a 2:2 saffron-chickpea ratio (C4), could be effective strategies for weed management in saffron in semiarid cropping systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.